NCT03536455View on ClinicalTrials.gov

Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

August 2, 2018

Study Completion Date

August 2, 2018

Conditions
Altitude Hypoxia
Interventions
DRUG

ACETAZOLAMIDE oral capsule

Administration of 1x125mg acetazolamide in the morning, 2x125mg in the evening, starting 24 hours before departure to 3'100m

DRUG

Placebo oral capsule

Administration of equally looking placebo capsules in the morning and evening, starting 24 hours before departure to 3'100m

Trial Locations (1)

720040

National Center of Cardiology and Internal Medicine, Bishkek

All Listed Sponsors
collaborator

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

lead

University of Zurich

OTHER

NCT03536455 - Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude | Biotech Hunter | Biotech Hunter